NewsBenzingaPiper Sandler mantiene una recomendación neutral sobre LENZ Therapeutics y reduce el precio objetivo a 5 dólares. Piper Sandler mantiene una recomendación neutral sobre LENZ Therapeutics y reduce el precio objetivo a 5 dólares. Benzinga 2026.10.19 16:22 (GMT+0) Open on Benzinga Other news Jones Trading Maintains Buy on Dynex Cap, Lowers Price Target to $12.5 Here's How Much $100 Invested In Gartner 20 Years Ago Would Be Worth Today Dorchester Minerals Enters Into An Agreement To Acquire Mineral And Royalty Interests; To Buy ~ 4,300 Net Royalty Acres In Williston Basin, North Dakota; Interests To Be Exchanged For 1,250,000 Common Units Of Dorchester Minerals Here's How Much $100 Invested In Fastenal 10 Years Ago Would Be Worth Today Servisfirst Bancshares Q3 2026 Earnings Call Transcript Scotiabank Maintains Sector Outperform on Whitecap Res, Raises Price Target to C$22
Dorchester Minerals Enters Into An Agreement To Acquire Mineral And Royalty Interests; To Buy ~ 4,300 Net Royalty Acres In Williston Basin, North Dakota; Interests To Be Exchanged For 1,250,000 Common Units Of Dorchester Minerals
